JCR Pharmaceuticals Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3701000006
JPY
588.00
-19 (-3.13%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
8,991.00
12,793.00
8,569.00
7,192.00
9,223.00
8,512.00
8,145.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
8,991.00
12,793.00
8,569.00
7,192.00
9,223.00
8,512.00
8,145.00
Raw Material Cost
2,480.00
2,005.00
2,395.00
4,374.00
2,722.00
2,141.00
2,287.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
151.00
78.00
79.00
52.00
40.00
37.00
26.00
Selling and Distribution Expenses
2,962.00
3,354.00
3,470.00
3,256.00
3,212.00
3,297.00
3,193.00
Other Expenses
538.60
440.90
326.90
545.40
330.90
336.40
314.90
Total Expenditure (Excl Depreciation)
10,979.00
9,846.00
9,213.00
13,136.00
9,283.00
8,839.00
8,655.00
Operating Profit (PBDIT) excl Other Income
-1988
2947
-644
-5944
-60
-327
-510
Other Income
490.00
420.00
-27.00
-103.00
339.00
-998.00
280.00
Operating Profit (PBDIT)
-939.00
4,088.00
67.00
-5,179.00
1,118.00
-484.00
596.00
Interest
151.00
78.00
79.00
52.00
40.00
37.00
26.00
Exceptional Items
1,882.00
0.00
0.00
0.00
0.00
437.00
627.00
Gross Profit (PBDT)
6,511.00
10,788.00
6,174.00
2,818.00
6,501.00
6,371.00
5,858.00
Depreciation
559.00
721.00
738.00
868.00
839.00
841.00
826.00
Profit Before Tax
231.00
3,292.00
-751.00
-6,097.00
239.00
-925.00
369.00
Tax
142.00
1,013.00
-180.00
-1,879.00
37.00
-40.00
164.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
34.00
2,256.00
-546.00
-4,183.00
115.00
-891.00
201.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
34.00
2,256.00
-546.00
-4,183.00
115.00
-891.00
201.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
55.00
21.00
-24.00
-34.00
87.00
7.00
3.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
89.00
2,277.00
-570.00
-4,217.00
202.00
-884.00
204.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
46,325.00
48,156.00
46,264.00
47,043.00
52,576.00
56,704.00
55,356.00
Earnings per share (EPS)
0.28
18.5
-4.48
-34.33
0.94
-7.14
1.61
Diluted Earnings per share
0.28
18.5
-4.48
-34.33
0.94
-7.14
1.61
Operating Profit Margin (Excl OI)
-22.11%
23.04%
-7.52%
-82.65%
-0.65%
-3.84%
-6.26%
Gross Profit Margin
8.79%
31.37%
-0.15%
-72.71%
11.69%
-0.99%
14.67%
PAT Margin
0.38%
17.63%
-6.37%
-58.16%
1.25%
-10.47%
2.47%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is -29.72% vs 49.29% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -96.09% vs 499.47% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -138.96% vs 3,802.13% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 93.59% vs -1.27% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of JCR Pharmaceuticals Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
8,991.00
56,021.00
-47,030.00
-83.95%
Other Operating Income
0.00
0.00
0.00
Total Operating income
8,991.00
56,021.00
-47,030.00
-83.95%
Raw Material Cost
2,480.00
38,941.00
-36,461.00
-93.63%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
151.00
589.00
-438.00
-74.36%
Selling and Distribution Expenses
2,962.00
5,963.00
-3,001.00
-50.33%
Other Expenses
538.60
296.20
242.40
81.84%
Total Expenditure (Excl Depreciation)
10,979.00
48,455.00
-37,476.00
-77.34%
Operating Profit (PBDIT) excl Other Income
-1,988.00
7,566.00
-9,554.00
-126.28%
Other Income
490.00
-136.00
626.00
460.29%
Operating Profit (PBDIT)
-939.00
7,430.00
-8,369.00
-112.64%
Interest
151.00
589.00
-438.00
-74.36%
Exceptional Items
1,882.00
0.00
1,882.00
Gross Profit (PBDT)
6,511.00
17,080.00
-10,569.00
-61.88%
Depreciation
559.00
0.00
559.00
Profit Before Tax
231.00
6,840.00
-6,609.00
-96.62%
Tax
142.00
1,966.00
-1,824.00
-92.78%
Provisions and contingencies
0
0
0.00
Profit After Tax
34.00
4,875.00
-4,841.00
-99.30%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
34.00
4,875.00
-4,841.00
-99.30%
Share in Profit of Associates
0
0
0.00
Minority Interest
55.00
0.00
55.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
89.00
4,875.00
-4,786.00
-98.17%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
46,325.00
1,78,800.00
-1,32,475.00
-74.09%
Earnings per share (EPS)
0.28
42.32
-42.04
-99.34%
Diluted Earnings per share
0.28
42.32
-42.04
-99.34%
Operating Profit Margin (Excl OI)
-22.11%
13.51%
0.00
-35.62%
Gross Profit Margin
8.79%
12.21%
0.00
-3.42%
PAT Margin
0.38%
8.70%
0.00
-8.32%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 899.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -29.72% vs 49.29% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -2.52% vs -2.36% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.90 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -96.09% vs 499.47% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -55.94% vs 329.55% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -142.90 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -138.96% vs 3,802.13% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -283.44% vs -57.82% in Dec 2024

Quarterly - Interest
Interest 15.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 93.59% vs -1.27% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 277.50% vs 73.91% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -22.11%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024